A. OBJECTIVE The primary goal of the UNC DDRC is to advance productive, innovative, collaborative research on the pathogenesis and treatment/prevention of mental retardation and neurodevelopmental disorders by providing DDRC Investigators with administrative and core research support in the context of a stimulating, interactive environment. The BMC advances this goal through three interdependent objectives, each of which reflects our expertise in behavioral measurement in humans and in mice, and our successful linkage of these two domains: 1. Traditional approaches to research in mental retardation and developmental disability have used standard, general phenotype measures like IQ, adaptive behavior, or global impressions. However, it has become increasingly apparent that the phenotypes associated with developmental disorders are complex and that a more detailed elucidation of these phenotypes facilitates the search for neural correlations, genetic mechanisms, and efficacious interventions. For example, global assessments of developmental status can be replaced with specific """"""""red flags"""""""" that are associated with abnormal brain development or gene function, and global clinical constructs (e.g., autism) can be refined into quantitative dimensional symptom measures that may be more directly linked to neurological and genetic variation. One overarching objective of the BMC is to develop innovative phenotyping procedures that can be used in humans and mice to tap behaviors associated with clinical syndromes. 2. The innovative phenotyping procedures developed in Objective 1 are of particular value when they are deployed in neurobiological and genetic studies. Our second objective is to facilitate the use of comprehensive phenotyping in neurobiological and genetic studies of clinical syndromes. Effective integration of behavior with neurobiology and genetics is facilitated through consulting with DDRC researchers regarding measurement and design, providing laboratory space and expertise, and further refinement of phenotyping procedures. The Mouse BPL provides researchers with a multifaceted behavioral phenotyping battery (described in detail below) that goes well beyond the level of assessment that could be sustained by an independent researcher, and the Human BPL provides laboratory space, equipment, and expertise for state-of-the-art behavioral phenotyping. 3. Finally, research on interventions evokes additional challenges such as the need to identify disorder-specific features that underlie functional impairment, to evoke behaviors in mice that could be related to clinical symptoms, and to ascertain relevant human populations in which interventions can be tested. A third objective of the BMC is to integrate innovative and comprehensive phenotypic methods in the context of clinical intervention studies.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
5P30HD003110-45
Application #
8380945
Study Section
Special Emphasis Panel (ZHD1-MRG-C)
Project Start
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
45
Fiscal Year
2012
Total Cost
$529,136
Indirect Cost
$123,187
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Robinson, Ashley N; Roberts, Jane E; Brady, Nancy C et al. (2016) Physiological Correlates of Maternal Responsivity in Mothers of Preschoolers With Fragile X Syndrome. Am J Intellect Dev Disabil 121:111-20
Judson, Matthew C; Wallace, Michael L; Sidorov, Michael S et al. (2016) GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility. Neuron 90:56-69
Klusek, Jessica; McGrath, Sara E; Abbeduto, Leonard et al. (2016) Pragmatic Language Features of Mothers With the FMR1 Premutation Are Associated With the Language Outcomes of Adolescents and Young Adults With Fragile X Syndrome. J Speech Lang Hear Res 59:49-61
Resendez, Shanna L; Jennings, Josh H; Ung, Randall L et al. (2016) Visualization of cortical, subcortical and deep brain neural circuit dynamics during naturalistic mammalian behavior with head-mounted microscopes and chronically implanted lenses. Nat Protoc 11:566-97
Hong, Junpyo; Vicory, Jared; Schulz, Jörn et al. (2016) Non-Euclidean classification of medically imaged objects via s-reps. Med Image Anal 31:37-45
Jha, Shaili C; Meltzer-Brody, Samantha; Steiner, Rachel J et al. (2016) Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study. Psychiatry Res 253:43-53
Pearson, Brandon L; Simon, Jeremy M; McCoy, Eric S et al. (2016) Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration. Nat Commun 7:11173
Mabb, Angela M; Simon, Jeremy M; King, Ian F et al. (2016) Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms. PLoS One 11:e0156439
Woynaroski, Tiffany; Yoder, Paul; Watson, Linda R (2016) Atypical Cross-Modal Profiles and Longitudinal Associations Between Vocabulary Scores in Initially Minimally Verbal Children With ASD. Autism Res 9:301-10
Kirby, Anne V; Little, Lauren M; Schultz, Beth et al. (2016) Development and Pilot of the Caregiver Strategies Inventory. Am J Occup Ther 70:7004360010p1-6

Showing the most recent 10 out of 307 publications